Thyroid

AbbVie/ M21-341

Study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism

» Study Details | Apply for the Study

Graves Disease

Immunovant/IMVT-1402-2502

Immunovant/IMVT-1402-2502 This study is testing IMVT-1402 vs Placebo in patients with Graves disease.

» Study Details | Apply for the Study

Type 1 Diabetes

Zucara/ZT01-CL-2001

Evaluates the effect of ZT-01 once nightly injection on nocturnal hypoglycemia

» Study Details | Apply for the Study

Type 2 Diabetes

Endogenex/ReCET study

Evaluate ReCET Intestinal Cellular Regeneration System in Type 2 Diabetes glucose control. Endoscopic procedure to promote growth of new cells in the small intestine.

Click on the link below for a video of the procedure:

https://vimeo.com/953640541/ce8d466e10?share=copy

» Study Details | Apply for the Study

Type 1 Diabetes

vTv Therapeutics, LLC/ TTP399-302

Cadisegliatin as Adjunctive Therapy in Type 1 Diabetes: A 52-Week Double-Blind, Randomized, Placebo-Controlled Phase 3 Study (CATT1)

» Study Details | Apply for the Study

Diabetes Devices

• Clinical Diagnosis of Type 1 or 2 Diabetes for 6 months or more 
• Willing to perform finger sticks for blood glucose reading multiple times per day
• Willing to wear up to 4 glucose sensor
• Willing to participate in office clinic days

» Study Details | Apply for the Study

Type 1 Diabetes

Elli Lilly and Company- I8F-MC-GPJA

Study Evaluating the Efficacy and Safety of Tirzepatide Once Weekly Compared to Placebo in Adult Participants with Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-1)

» Study Details | Apply for the Study

Type 2 Diabetes

GZFD is a clinical research study from Eli Lilly and Company. It is testing if an investigational medicine (a medicine being studied) may help treat people with type 2 diabetes, who are already taking injectable incretin medications, to lower their blood sugar levels. Incretin medications are a type of medicine used to help treat type 2 diabetes.

» Study Details | Apply for the Study

Type 2 Diabetes

The BP45703 study aims to see if the oral study medication RO7795081, compared with semaglutide, alone or placebo may help better manage blood sugar.

» Study Details | Apply for the Study

Type 1 Diabetes

A Phase 1b/2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-103 in Subjects Ages 12-35 with Recent Onset Stage 3 Type 1 Diabetes.

» Study Details | Apply for the Study

Type 2 Diabetes

VK2735 for Weight Management Phase 3 in Adults with Type 2 Diabetes

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants with Type 2 Diabetes who are Obese, or Overweight (VANQUISH-2)

» Study Details | Apply for the Study

Type 2 Diabetes

Participating in clinical trial has a potential to improve future treatment options for people living with Type 2 Diabetes.

Our site is continuously enrolling new studies and are available to answer your questions about our future research studies.  To be added to our future research list click on study details below.

» Study Details | Apply for the Study

Weight Loss Trials

Participating in this clinical trial has the potential to improve future treatment options for people living with excess weight.

Our site is continuously enrolling new studies and are available to answer your questions about our future research studies.  To be added to our future research list click on study details below.

» Study Details | Apply for the Study